Ignite Creation Date:
2024-05-05 @ 11:12 PM
Last Modification Date:
2024-10-26 @ 10:29 AM
Study NCT ID:
NCT01272258
Status:
WITHDRAWN
Last Update Posted:
2017-02-02
First Post:
2011-01-05
Brief Title:
A Trial of Observed Long-acting Anti-HIV Treatment With a Monoclonal CCR5 Antibody PRO 140 as an Adjunct to a New Optimized Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence
Sponsor:
CytoDyn Inc
Organization:
CytoDyn Inc
Organization Data
Organization:
CytoDyn Inc
Class:
INDUSTRY
Study ID:
PRO 140 2102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CytoDyn Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None